Taiwan · Delayed Price · Currency is TWD Bioteque Statistics
Total Valuation
Bioteque has a market cap or net worth of TWD 8.00 billion. The enterprise value is 6.88 billion.
| Market Cap | 8.00B |
| Enterprise Value | 6.88B |
Important Dates
The last earnings date was Thursday, September 11, 2025.
| Earnings Date | Sep 11, 2025 |
| Ex-Dividend Date | Jul 28, 2025 |
Share Statistics
Bioteque has 69.30 million shares outstanding. The number of shares has increased by 0.03% in one year.
| Current Share Class | 69.30M |
| Shares Outstanding | 69.30M |
| Shares Change (YoY) | +0.03% |
| Shares Change (QoQ) | -0.19% |
| Owned by Insiders (%) | 3.84% |
| Owned by Institutions (%) | 8.33% |
| Float | 55.26M |
Valuation Ratios
The trailing PE ratio is 25.36.
| PE Ratio | 25.36 |
| Forward PE | n/a |
| PS Ratio | 3.80 |
| PB Ratio | 2.43 |
| P/TBV Ratio | 2.43 |
| P/FCF Ratio | 11.92 |
| P/OCF Ratio | 11.36 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 8.17, with an EV/FCF ratio of 10.24.
| EV / Earnings | 13.10 |
| EV / Sales | 3.26 |
| EV / EBITDA | 8.17 |
| EV / EBIT | 10.22 |
| EV / FCF | 10.24 |
Financial Position
The company has a current ratio of 2.70, with a Debt / Equity ratio of 0.21.
| Current Ratio | 2.70 |
| Quick Ratio | 2.33 |
| Debt / Equity | 0.21 |
| Debt / EBITDA | 0.81 |
| Debt / FCF | 1.01 |
| Interest Coverage | 81.61 |
Financial Efficiency
Return on equity (ROE) is 16.29% and return on invested capital (ROIC) is 10.57%.
| Return on Equity (ROE) | 16.29% |
| Return on Assets (ROA) | 8.77% |
| Return on Invested Capital (ROIC) | 10.57% |
| Return on Capital Employed (ROCE) | 17.42% |
| Revenue Per Employee | n/a |
| Profits Per Employee | n/a |
| Employee Count | n/a |
| Asset Turnover | 0.44 |
| Inventory Turnover | 4.11 |
Taxes
In the past 12 months, Bioteque has paid 141.31 million in taxes.
| Income Tax | 141.31M |
| Effective Tax Rate | 21.21% |
Stock Price Statistics
The stock price has decreased by -10.81% in the last 52 weeks. The beta is 0.10, so Bioteque's price volatility has been lower than the market average.
| Beta (5Y) | 0.10 |
| 52-Week Price Change | -10.81% |
| 50-Day Moving Average | 115.50 |
| 200-Day Moving Average | 120.74 |
| Relative Strength Index (RSI) | 46.11 |
| Average Volume (20 Days) | 51,865 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Bioteque had revenue of TWD 2.11 billion and earned 525.05 million in profits. Earnings per share was 4.55.
| Revenue | 2.11B |
| Gross Profit | 930.73M |
| Operating Income | 672.64M |
| Pretax Income | 666.37M |
| Net Income | 525.05M |
| EBITDA | 826.78M |
| EBIT | 672.64M |
| Earnings Per Share (EPS) | 4.55 |
Balance Sheet
The company has 1.81 billion in cash and 678.70 million in debt, giving a net cash position of 1.13 billion or 16.28 per share.
| Cash & Cash Equivalents | 1.81B |
| Total Debt | 678.70M |
| Net Cash | 1.13B |
| Net Cash Per Share | 16.28 |
| Equity (Book Value) | 3.29B |
| Book Value Per Share | 47.48 |
| Working Capital | 1.51B |
Cash Flow
In the last 12 months, operating cash flow was 704.50 million and capital expenditures -33.04 million, giving a free cash flow of 671.46 million.
| Operating Cash Flow | 704.50M |
| Capital Expenditures | -33.04M |
| Free Cash Flow | 671.46M |
| FCF Per Share | 9.69 |
Margins
Gross margin is 44.18%, with operating and profit margins of 31.93% and 24.92%.
| Gross Margin | 44.18% |
| Operating Margin | 31.93% |
| Pretax Margin | 31.63% |
| Profit Margin | 24.92% |
| EBITDA Margin | 39.25% |
| EBIT Margin | 31.93% |
| FCF Margin | 31.87% |
Dividends & Yields
This stock pays an annual dividend of 5.00, which amounts to a dividend yield of 4.31%.
| Dividend Per Share | 5.00 |
| Dividend Yield | 4.31% |
| Dividend Growth (YoY) | 11.11% |
| Years of Dividend Growth | n/a |
| Payout Ratio | 59.39% |
| Buyback Yield | -0.03% |
| Shareholder Yield | 4.32% |
| Earnings Yield | 6.56% |
| FCF Yield | 8.39% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Stock Splits
The last stock split was on August 20, 2015. It was a reverse split with a ratio of 0.8006917977.
| Last Split Date | Aug 20, 2015 |
| Split Type | Reverse |
| Split Ratio | 0.8006917977 |
Scores
Bioteque has an Altman Z-Score of 5.56 and a Piotroski F-Score of 8.
| Altman Z-Score | 5.56 |
| Piotroski F-Score | 8 |